OXULAR LTD has a total of 42 patent applications. It increased the IP activity by 45.0%. Its first patent ever was published in 2015. It filed its patents most often in United Kingdom, EPO (European Patent Office) and United States. Its main competitors in its focus markets medical technology and pharmaceuticals are LICONSA LABORATORIOS SA, THERACOAT LTD and DISCOVERY LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 10 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | United States | 6 | |
#4 | Australia | 5 | |
#5 | Republic of Korea | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | China | 3 | |
#8 | Brazil | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Syringes | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Conston Stanley R | 31 |
#2 | Yamamoto Ronald K | 23 |
#3 | Bley Robert Steven | 22 |
#4 | Nguyen Tien T | 14 |
#5 | Phan Loc X | 12 |
#6 | Martinez Dillon Daniel | 12 |
#7 | Lunsford John P | 12 |
#8 | Ronald K Yamamoto | 9 |
#9 | Stanley R Conston | 9 |
#10 | Robert Steven Bley | 8 |
Publication | Filing date | Title |
---|---|---|
GB201917487D0 | Methods for the treatment of retinoblastoma | |
GB201917493D0 | methods for the treatment of uveal melanoma | |
EP3681469A1 | Ophthalmic drug compositions | |
AU2017235845A1 | Ophthalmic delivery device and ophthalmic drug compositions | |
GB201615804D0 | Ophthalmic Injection device | |
AU2015316710A1 | Ophthalmic drug compositions | |
KR20170060074A | Ophthalmic delivery device |